2023 Press Releases
2022 Press Releases
-
Oct 2022
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
Oct 2022
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
Aug 2022
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
May 2022
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
May 2022
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Apr 2022
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
-
Apr 2022
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
-
Mar 2022
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
-
Jan 2022
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
2021 Press Releases
-
Jun 2021
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
Mar 2021
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
Feb 2021
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Jan 2021
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020 Press Releases
-
Oct 2022
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
Oct 2022
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
Aug 2022
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
May 2022
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
May 2022
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Apr 2022
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
-
Apr 2022
Benaroya Research Institute Team Examines COVID Vaccine Response in People Under Treatment for MS and Other Autoimmune Diseases
-
Mar 2022
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
-
Jan 2022
BRI Research Team Links Down Syndrome, Aging and Autoimmunity
2021 Press Releases
-
Jun 2021
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
-
Mar 2021
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
-
Feb 2021
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
-
Jan 2021
Kay Branz to Retire From Benaroya Research Institute at Virginia Mason
2020 Press Releases
Jun 2021
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
Mar 2021
New Researcher Dr. Oliver Harrison at the Benaroya Research Institute at Virginia Mason Receives $2.9 Million NIH R01 Grant to Study How the Immune System Responds to the Microbiome
Feb 2021
New Study from the Benaroya Research Institute at Virginia Mason Finds "COVID-19 Immune Landscape Is Dynamically and Reversibly Correlated with Disease Severity"
Jan 2021